Ligelizumab impairs <scp>IgE</scp> ‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores <scp>IFN</scp> ‐α production and <scp>FOXP3</scp> <sup>+</sup> Treg generation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ligelizumab impairs IgE ‐binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN ‐α production and FOXP3 ⁺ Treg generation

Published:2022-11-12 Issue:4 Volume:78 Page:1060-1072
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Benito‐Villalvilla Cristina¹^ORCID,de la Rocha‐Muñoz Andrés¹²^ORCID,López‐Abente Jacobo¹,Eggel Alexander³⁴^ORCID,Bottoli Iván⁵,Severin Thomas⁵,Woisetschläger Maximilian⁵,Palomares Oscar¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology School of Chemistry Complutense University Madrid Spain

2. Autonomous University of Madrid Madrid Spain

3. Department of BioMedical Research University of Bern Bern Switzerland

4. Department of Rheumatology and Immunology University Hospital of Bern Bern Switzerland

5. Novartis Pharma AG Basel Switzerland

Funder

Ministerio de Ciencia e Innovación

Novartis Pharma

Novartis

Universidad Complutense de Madrid

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15567

Reference62 articles.

1. Regulatory T cells and immunoglobulin E: A new therapeutic link for autoimmunity?

2. What is the contribution of IgE to nasal polyposis?

3. Immunoglobulin E-Mediated Autoimmunity

4. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

5. Past, present, and future of anti‐IgE biologics

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoreactive IgE: Pathogenic role and therapeutic target in autoimmune diseases;Allergy;2023-08-09

2. Type 2 chronic inflammatory diseases: targets, therapies and unmet needs;Nature Reviews Drug Discovery;2023-08-01

3. Anti–immunoglobulin E for food allergy;Annals of Allergy, Asthma & Immunology;2023-07

4. Treatment of food allergy;Annals of Allergy, Asthma & Immunology;2023-07

5. Self-reactive IgE and anti-IgE therapy in autoimmune diseases;Frontiers in Pharmacology;2023-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3